Table 2 Adjusted hazard ratio of determine factors associated with prognosis of patients in univariate model for patients with T2-T3 esophageal SCC.

From: Survival benefit of surgery to patients with esophageal squamous cell carcinoma

Variable

HR

95% CI

P value

Age

 <65

Ref

  

 >=65

1.35

1.12–1.63

0.002

Gender

 Female

Ref

  

 Male

1.48

1.00–2.18

0.048

Clinical T stage

 T2

Ref

  

 T3

1.80

1.43–2.27

<0.001

Clinical N stage

 N0

Ref

  

 N(+)

1.85

1.43–2.40

<0.001

Treatment

 Definite CCRT

Ref

  

 Surgery+/−Neo/adjuvant Tx

0.44

0.36–0.54

<0.001

 Palliative treatment

1.31

1.05–1.62

0.015

Back to article page